Klinikum der Universität München

München, Bavaria 81377

0 studies enrolling now · 6 studies all time

What they study most

Alzheimer's Disease, Alzheimer's Disease Dementia, Chronic Cluster Headache, Episodic Cluster Headache, Mild Cognitive Impairment Due to Alzheimer's Disease, Rheumatoid Arthritis, Soft Tissue Sarcoma, Systemic Lupus Erythematosus

Studies at this site

• A Study to Learn About the Safety of Diranersen (BIIB080) Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age — Running, not enrolling
• A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus — Stopped early
• A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma — Completed
• An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis — Completed
• A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache — Completed
• A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia — Stopped early